Another study that pooled and analyzed patient‐level data from 15 RCTs in patients with T2DM treated with insulin glargine indicated that increasing basal insulin doses above 0.5 IU/kg was not associated with improvement in glycemic control.49 The gene discussed is INS; the disease is type 2 diabetes mellitus.